Developer docs
API playgroundTry for free, no card

Search company profiles

World Duchenne Organization

Full company profile

uuid000euju

Namestring
World Duchenne Organization
Legal namestring
Stichting World Duchenne Organization
Company typeenum
Private
Founded yearint
2005
Descriptiontext

World Duchenne Organization (WDO), legally Stichting World Duchenne Organization, is a Dutch nonprofit patient advocacy organization that has connected the global Duchenne and Becker muscular dystrophy (DMD/BMD) community since 2005. It serves families and caregivers of people with dystrophinopathies, clinicians and researchers, and patient advocates through a portfolio of programs: the annual World Duchenne Awareness Day, the annual Duchenne Care Conference (700+ registrants from 72 countries in the most recent edition, moving to a fully online model in 2026), and the Duchenne Patient Academy (500+ trained advocates from 55 countries since 2018, co-organized with the Duchenne Data Foundation). Additional programs include the Accredited Duchenne Centers Program, the DMD Emergency Program, the multilingual Duchenne Family Guide, and the FAIR Data for Duchenne initiative.

WDO's operating model is community-led and content-distribution driven rather than technology-platform driven. Its core "technology" is a comprehensive website hosting a scientific library, an online conference delivery layer (Zoom), and an online application system for academy admissions. It also acts as a patient-voice partner in several EU-funded research initiatives — BIND (brain involvement in dystrophinopathies, 300+ patients across seven EU centers), BEAMER, ERDERA, EURO-NMD Registry Hub, and Trials@Home — and is formally recognized by the European Medicines Agency, EURORDIS, the European Patients' Forum, Rare Diseases International, and EUPATI.

WDO is funded by individual donations, pharmaceutical and biotechnology event sponsorships (PTC Therapeutics, Sarepta, Roche, BioMarin, Italfarmaco, Santhera, Solid Biosciences, and Wave Life Sciences have sponsored the Duchenne Patient Academy), and EU research grants. All flagship community-facing services are free to participants; there is no consumer or enterprise pricing model. Revenue figures are not publicly disclosed. The organization is governed by a board and small staff (11–50 employees), headquartered in Amsterdam with operating presence across Europe and a growing transatlantic footprint via its partnership with Parent Project Muscular Dystrophy (PPMD).

Short descriptiontext

World Duchenne Organization is a Dutch nonprofit founded in 2005 that connects the global Duchenne and Becker muscular dystrophy community through awareness campaigns, an annual care conference, a patient advocate training academy, and EU-funded research partnerships, serving patients, families, clinicians, and advocates.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersVeenendaal, Netherlands
HQ citystring
Veenendaal
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient advocacy services, rare disease nonprofit, muscular dystrophy support, patient advocate training, healthcare awareness campaigns
Industry3 codes
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code3 codes
  • Other Individual and Family Services624190
  • Scientific Research and Development Services5417
  • Management, Scientific, and Technical Consulting Services5416
SIC code3 codes
  • Services-Membership Organizations8600
  • Services-Misc Health & Allied Services, Nec8090
  • Services-Commercial Physical & Biological Research8731
Product category
Patient Advocacy and Rare Disease Support Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Grants
TypeOthers
Description

WDO operates as a nonprofit charitable foundation (Stichting World Duchenne Organization) that relies on donations from individuals, families, and organizations to fund its mission of improving treatment, quality of life, and long-term outlook for people affected by Duchenne and Becker muscular dystrophy. The organization accepts donations via PayPal and international bank transfers.

worldduchenne.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details1 tier
1Free participation with registration required
ModelOtherBilling cadenceOne time
Notes

Duchenne Care Conference 2026 is free to attend but requires registration. The conference takes place online via Zoom on May 26-27, 2026.

worldduchenne.org
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

World Duchenne Organization is a Dutch nonprofit patient advocacy foundation that serves as a global hub for the Duchenne and Becker muscular dystrophy (DMD/BMD) community. It offers an annual international Duchenne Care Conference, the Duchenne Patient Academy online advocate training program, the annual World Duchenne Awareness Day campaign, and contributes to EU-funded research initiatives (BIND, BEAMER, ERDERA, EURO-NMD Registry Hub, Trials@Home). Its core product is a comprehensive information and community platform delivered through its website, supporting families, caregivers, clinicians, and patient organizations with condition information, care standards, and clinical trial guidance.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Over 500 patient advocates trained from 55 countries since 2018 through Duchenne Patient Academy
+2 more records
Product overview1 text field

The World Duchenne Organization operates primarily as a digital advocacy and information platform rather than a software product company. Its portfolio consists of patient-focused services and programs including the Duchenne Care Conference (annual international care meeting), Duchenne Patient Academy (patient advocate training), and the BIND Project (brain involvement research). The organization also runs awareness campaigns like World Duchenne Awareness Day, quality programs such as the Accredited Duchenne Centers Program, emergency assistance through the DMD Emergency Program, and educational resources including the Duchenne Family Guide. These programs are delivered through its website platform which serves as the central hub for information, news, research library, and community resources for the global Duchenne and Becker muscular dystrophy community.

Product and service7 records
1Duchenne Care Conference
CategoryInternational conference / professional education event
Description

Annual international meeting bringing together clinicians, researchers, and patient organization representatives to share knowledge and advances in Duchenne and Becker MD care. Free to attend with registration required; previous edition attracted 700+ registrants from 72 countries.

2Duchenne Patient Academy
CategoryPatient advocate training program
Description

Online training event for Duchenne and Becker patient advocates covering community building, drug development, patient advocacy, Standards of Care, and communication. Delivered in collaboration with Duchenne Data Foundation; has trained over 500 patient advocates from 55 countries since 2018.

3BIND Project (Brain Involvement in Dystrophinopathies)
CategoryInternational research consortium / project
Description

International research initiative dedicated to studying learning and behavioural challenges in DMD/BMD patients, with collected clinical data from more than 300 patients across seven EU centers. European Commission-funded.

4World Duchenne Awareness Day
CategoryGlobal awareness campaign
Description

Annual global awareness initiative on Duchenne and Becker muscular dystrophy featuring documentary premieres, the Bad Shirt Friday campaign, and themed community engagement.

5Accredited Duchenne Centers Program
CategoryClinical care quality accreditation program
Description

Program that accredits healthcare centers meeting standards of care for Duchenne patients, providing a quality assurance framework for clinical care delivery.

6DMD Emergency Program
CategoryCommunity emergency response program
Description

Emergency assistance program activated during crises affecting the Duchenne and Becker community, providing rapid response support to patients and families.

7Duchenne Family Guide
CategoryFamily education resource / clinical standards guide
Description

Comprehensive guide implementing updated standards of care for Duchenne patients, available in multiple languages, for use by families and caregivers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership22 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-05
Description

US-based partner collaborating on World Duchenne Awareness Day 2025 initiatives, including the Bad Shirt Friday campaign and United Nations documentary premiere in New York.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Biotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

Strategic tierMinorTypeOthersAnnounced on2024-10-30
Description

Biotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.

10Duchenne Data Foundation
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-30
Description

Collaborative partner in organizing Duchenne Patient Academy. DDF and WDO work together to provide intensive training for patient advocates on key aspects needed to make a meaningful impact in the DMD/BMD field.

worldduchenne.org
11BIND Project Consortium
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-09-23
Description

International research consortium including seven EU centers focused on understanding brain involvement in dystrophinopathies. Consortium members include researchers from CNRS Paris-Saclay, Leiden University Medical Center, Kempenhaeghe, and other institutions.

worldduchenne.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Regulatory partner providing training opportunities and collaboration on medicines R&D, with WDO listed as a related organization on their website.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partner for patient empowerment initiatives. WDO provides the EPF Toolkit on Patient Empowerment and participates in EPF Summer Training Course.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Alliance partner in the rare diseases community. WDO offers EURORDIS Open Academy training to patient advocates and maintains organizational partnership.

15Rare Diseases International
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Global advocacy partner for rare diseases. WDO participates in #Resolution4Rare initiatives and maintains alliance membership.

worldduchenne.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Educational partner providing the EUPATI Toolbox on Medicines R&D and EUPATI Patient Expert Training Course to patient advocates.

17Share4Rare
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Platform partner providing the Share4Rare Toolkit on Patient Advocacy as part of WDO's advocacy tools.

worldduchenne.org
18European Neuromuscular Centre (ENMC)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Research partner hosting international workshops on Duchenne muscular dystrophy topics. WDO collaborates on workshops such as the bone protective therapy workshop.

worldduchenne.org
19EU Project: BEAMER
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded research project in which WDO participates as a partner organization.

worldduchenne.org
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded rare disease research partnership in which WDO participates as a partner organization.

21EU Project: EURO-NMD Registry Hub
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded registry project for neuromuscular diseases in which WDO participates as a partner organization.

worldduchenne.org
22EU Project: Trials@Home
Strategic tierCoreTypeStrategic or Co-development Partner
Description

EU-funded project on decentralised clinical trials in which WDO participates as a partner organization.

worldduchenne.org
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

UK-focused DMD patient advocacy and research funder. Operates as a national-level peer with overlapping mission in cure acceleration, family support, and clinical trial infrastructure.

TypeBroad incumbent
Description

Large US-based nonprofit covering multiple neuromuscular diseases including DMD. MDA operates a broader portfolio but is frequently cited alongside WDO in DMD/BMD advocacy and research contexts.

TypeDirect peer
Description

European umbrella alliance for rare disease patient organizations. WDO is a member and strategic partner, making EURORDIS a direct peer in pan-European rare disease advocacy.

TypeBroad incumbent
Description

Major French neuromuscular disease organization and research funder. Comparable scale and mission in funding neuromuscular research and supporting affected families across multiple conditions.

5Rare Diseases International
TypeDirect peer
Description

Global alliance of rare disease patient organizations. WDO participates in the #Resolution4Rare campaign, making it a peer in international rare disease policy advocacy.

TypeDirect peer
Description

Leading US-based DMD/BMD patient advocacy organization. WDO co-organized the 2025 World Duchenne Awareness Day with PPMD, indicating close peer-level collaboration on global advocacy campaigns.

TypeBroad incumbent
Description

Premier US rare disease umbrella organization. Comparable role in the US rare disease ecosystem that EURORDIS plays in Europe, with overlapping policy advocacy and patient empowerment programs.

TypeBroad incumbent
Description

EU-level cross-disease patient advocacy umbrella. WDO supplies EPF's Toolkit on Patient Empowerment and participates in EPF Summer Training, positioning it as a peer in pan-European patient empowerment work.

TypeDirect peer
Description

Collaborative partner organizing the Duchenne Patient Academy with WDO. Focused on data infrastructure for DMD research, making it a tightly coupled peer in research and advocacy.

TypeDirect peer
Description

Global neuromuscular disease research network. WDO participates in Euro-NMD Registry Hub with TREAT-NMD-affiliated institutions, working on the same patient registry and trial-readiness infrastructure.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

World Duchenne Organization

Patient Advocacy and Rare Disease Support Servicesworldduchenne.org

World Duchenne Organization is a Dutch nonprofit founded in 2005 that connects the global Duchenne and Becker muscular dystrophy community through awareness campaigns, an annual care conference, a patient advocate training academy, and EU-funded research partnerships, serving patients, families, clinicians, and advocates.

What World Duchenne Organization does

World Duchenne Organization (WDO), legally Stichting World Duchenne Organization, is a Dutch nonprofit patient advocacy organization that has connected the global Duchenne and Becker muscular dystrophy (DMD/BMD) community since 2005. It serves families and caregivers of people with dystrophinopathies, clinicians and researchers, and patient advocates through a portfolio of programs: the annual World Duchenne Awareness Day, the annual Duchenne Care Conference (700+ registrants from 72 countries in the most recent edition, moving to a fully online model in 2026), and the Duchenne Patient Academy (500+ trained advocates from 55 countries since 2018, co-organized with the Duchenne Data Foundation). Additional programs include the Accredited Duchenne Centers Program, the DMD Emergency Program, the multilingual Duchenne Family Guide, and the FAIR Data for Duchenne initiative.

WDO's operating model is community-led and content-distribution driven rather than technology-platform driven. Its core "technology" is a comprehensive website hosting a scientific library, an online conference delivery layer (Zoom), and an online application system for academy admissions. It also acts as a patient-voice partner in several EU-funded research initiatives — BIND (brain involvement in dystrophinopathies, 300+ patients across seven EU centers), BEAMER, ERDERA, EURO-NMD Registry Hub, and Trials@Home — and is formally recognized by the European Medicines Agency, EURORDIS, the European Patients' Forum, Rare Diseases International, and EUPATI.

WDO is funded by individual donations, pharmaceutical and biotechnology event sponsorships (PTC Therapeutics, Sarepta, Roche, BioMarin, Italfarmaco, Santhera, Solid Biosciences, and Wave Life Sciences have sponsored the Duchenne Patient Academy), and EU research grants. All flagship community-facing services are free to participants; there is no consumer or enterprise pricing model. Revenue figures are not publicly disclosed. The organization is governed by a board and small staff (11–50 employees), headquartered in Amsterdam with operating presence across Europe and a growing transatlantic footprint via its partnership with Parent Project Muscular Dystrophy (PPMD).

World Duchenne Organization firmographics

Firmographics
Name
World Duchenne Organization
Legal name
Stichting World Duchenne Organization
Website
https://worldduchenne.org
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
1–10 employees
Short description
World Duchenne Organization is a Dutch nonprofit founded in 2005 that connects the global Duchenne and Becker muscular dystrophy community through awareness campaigns, an annual care conference, a patient advocate training academy, and EU-funded research partnerships, serving patients, families, clinicians, and advocates.
Ownership category
akta.pro rank

World Duchenne Organization industry classification

Industry
Product category
Patient Advocacy and Rare Disease Support Services
NAICS
Other Individual and Family Services (624190), Scientific Research and Development Services (5417), Management, Scientific, and Technical Consulting Services (5416)
SIC
Services-Membership Organizations (8600), Services-Misc Health & Allied Services, Nec (8090), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYBPAGACAA
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
SECONDARYHLAJAKAN
Global Health Research, Evidence & Technical Assistance Organizations
Healthcare & Life Sciences/Public Health, Government & Regulators/Global Health & Development Agencies (NGOs/Multilaterals)
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Patient advocacy services
  • Rare disease nonprofit
  • Muscular dystrophy support
  • Patient advocate training
  • Healthcare awareness campaigns

Where World Duchenne Organization is headquartered

Location

Headquarters

HQ city
Veenendaal
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

World Duchenne Organization business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Donations and Grants: WDO operates as a nonprofit charitable foundation (Stichting World Duchenne Organization) that relies on donations from individuals, families, and organizations to fund its mission of improving treatment, quality of life, and long-term outlook for people affected by Duchenne and Becker muscular dystrophy. The organization accepts donations via PayPal and international bank transfers.

Pricing tiers

ModelBillingPrice
OtherOne timeFree participation with registration required

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

World Duchenne Organization product offering

Product offering

Core offering

World Duchenne Organization is a Dutch nonprofit patient advocacy foundation that serves as a global hub for the Duchenne and Becker muscular dystrophy (DMD/BMD) community. It offers an annual international Duchenne Care Conference, the Duchenne Patient Academy online advocate training program, the annual World Duchenne Awareness Day campaign, and contributes to EU-funded research initiatives (BIND, BEAMER, ERDERA, EURO-NMD Registry Hub, Trials@Home). Its core product is a comprehensive information and community platform delivered through its website, supporting families, caregivers, clinicians, and patient organizations with condition information, care standards, and clinical trial guidance.

Product overview

The World Duchenne Organization operates primarily as a digital advocacy and information platform rather than a software product company. Its portfolio consists of patient-focused services and programs including the Duchenne Care Conference (annual international care meeting), Duchenne Patient Academy (patient advocate training), and the BIND Project (brain involvement research). The organization also runs awareness campaigns like World Duchenne Awareness Day, quality programs such as the Accredited Duchenne Centers Program, emergency assistance through the DMD Emergency Program, and educational resources including the Duchenne Family Guide. These programs are delivered through its website platform which serves as the central hub for information, news, research library, and community resources for the global Duchenne and Becker muscular dystrophy community.

Differentiator

Problem solved

Functional benefit

Products and services

  • Duchenne Care Conference Annual international meeting bringing together clinicians, researchers, and patient organization representatives to share knowledge and advances in Duchenne and Becker MD care. Free to attend with registration required; previous edition attracted 700+ registrants from 72 countries.
  • Duchenne Patient Academy Online training event for Duchenne and Becker patient advocates covering community building, drug development, patient advocacy, Standards of Care, and communication. Delivered in collaboration with Duchenne Data Foundation; has trained over 500 patient advocates from 55 countries since 2018.
  • BIND Project (Brain Involvement in Dystrophinopathies) International research initiative dedicated to studying learning and behavioural challenges in DMD/BMD patients, with collected clinical data from more than 300 patients across seven EU centers. European Commission-funded.
  • World Duchenne Awareness Day Annual global awareness initiative on Duchenne and Becker muscular dystrophy featuring documentary premieres, the Bad Shirt Friday campaign, and themed community engagement.
  • Accredited Duchenne Centers Program Program that accredits healthcare centers meeting standards of care for Duchenne patients, providing a quality assurance framework for clinical care delivery.
  • DMD Emergency Program Emergency assistance program activated during crises affecting the Duchenne and Becker community, providing rapid response support to patients and families.
  • Duchenne Family Guide Comprehensive guide implementing updated standards of care for Duchenne patients, available in multiple languages, for use by families and caregivers.

Quantifiable outcome

  • Over 500 patient advocates trained from 55 countries since 2018 through Duchenne Patient Academy
  • +2 more outcomes

Companies that use World Duchenne Organization

Customer profile

Segments3 records

Ideal customer profiles4 records

World Duchenne Organization technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

World Duchenne Organization partnerships and signals

Strategic signal

Partnerships

22 partnerships are on record, tiered core and minor.

  • Parent Project Muscular Dystrophy (PPMD)coreStrategic or Co-development Partner · 5 September 2025US-based partner collaborating on World Duchenne Awareness Day 2025 initiatives, including the Bad Shirt Friday campaign and United Nations documentary premiere in New York.
  • PTC TherapeuticsminorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • Sarepta TherapeuticsminorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • RocheminorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • BioMarinminorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • ItalfarmacominorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • SantheraminorOthers · 30 October 2024Pharmaceutical company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • Solid BioSciencesminorOthers · 30 October 2024Biotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • Wave Life SciencesminorOthers · 30 October 2024Biotechnology company sponsor of Duchenne Patient Academy 2024, providing financial support for the training program for patient advocates.
  • Duchenne Data FoundationcoreStrategic or Co-development Partner · 30 October 2024Collaborative partner in organizing Duchenne Patient Academy. DDF and WDO work together to provide intensive training for patient advocates on key aspects needed to make a meaningful impact in the DMD/BMD field.
  • BIND Project ConsortiumcoreStrategic or Co-development Partner · 23 September 2024International research consortium including seven EU centers focused on understanding brain involvement in dystrophinopathies. Consortium members include researchers from CNRS Paris-Saclay, Leiden University Medical Center, Kempenhaeghe, and other institutions.
  • European Medicines Agency (EMA)coreStrategic or Co-development PartnerRegulatory partner providing training opportunities and collaboration on medicines R&D, with WDO listed as a related organization on their website.
  • European Patients Forum (EPF)coreStrategic or Co-development PartnerStrategic partner for patient empowerment initiatives. WDO provides the EPF Toolkit on Patient Empowerment and participates in EPF Summer Training Course.
  • EURORDIScoreStrategic or Co-development PartnerAlliance partner in the rare diseases community. WDO offers EURORDIS Open Academy training to patient advocates and maintains organizational partnership.
  • Rare Diseases InternationalcoreStrategic or Co-development PartnerGlobal advocacy partner for rare diseases. WDO participates in #Resolution4Rare initiatives and maintains alliance membership.
  • EUPATIcoreStrategic or Co-development PartnerEducational partner providing the EUPATI Toolbox on Medicines R&D and EUPATI Patient Expert Training Course to patient advocates.
  • Share4RareminorStrategic or Co-development PartnerPlatform partner providing the Share4Rare Toolkit on Patient Advocacy as part of WDO's advocacy tools.
  • European Neuromuscular Centre (ENMC)coreStrategic or Co-development PartnerResearch partner hosting international workshops on Duchenne muscular dystrophy topics. WDO collaborates on workshops such as the bone protective therapy workshop.
  • EU Project: BEAMERcoreStrategic or Co-development PartnerEU-funded research project in which WDO participates as a partner organization.
  • EU Project: ERDERAcoreStrategic or Co-development PartnerEU-funded rare disease research partnership in which WDO participates as a partner organization.
  • EU Project: EURO-NMD Registry HubcoreStrategic or Co-development PartnerEU-funded registry project for neuromuscular diseases in which WDO participates as a partner organization.
  • EU Project: Trials@HomecoreStrategic or Co-development PartnerEU-funded project on decentralised clinical trials in which WDO participates as a partner organization.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

World Duchenne Organization competitors and assessment

Company assessment

Direct peers

  • Duchenne UK: UK-focused DMD patient advocacy and research funder. Operates as a national-level peer with overlapping mission in cure acceleration, family support, and clinical trial infrastructure.
  • EURORDIS - Rare Diseases Europe: European umbrella alliance for rare disease patient organizations. WDO is a member and strategic partner, making EURORDIS a direct peer in pan-European rare disease advocacy.
  • Rare Diseases International: Global alliance of rare disease patient organizations. WDO participates in the #Resolution4Rare campaign, making it a peer in international rare disease policy advocacy.
  • Parent Project Muscular Dystrophy (PPMD): Leading US-based DMD/BMD patient advocacy organization. WDO co-organized the 2025 World Duchenne Awareness Day with PPMD, indicating close peer-level collaboration on global advocacy campaigns.
  • Duchenne Data Foundation: Collaborative partner organizing the Duchenne Patient Academy with WDO. Focused on data infrastructure for DMD research, making it a tightly coupled peer in research and advocacy.
  • TREAT-NMD Alliance: Global neuromuscular disease research network. WDO participates in Euro-NMD Registry Hub with TREAT-NMD-affiliated institutions, working on the same patient registry and trial-readiness infrastructure.

Broad incumbents

  • Muscular Dystrophy Association (MDA): Large US-based nonprofit covering multiple neuromuscular diseases including DMD. MDA operates a broader portfolio but is frequently cited alongside WDO in DMD/BMD advocacy and research contexts.
  • AFM-Téléthon: Major French neuromuscular disease organization and research funder. Comparable scale and mission in funding neuromuscular research and supporting affected families across multiple conditions.
  • National Organization for Rare Disorders (NORD): Premier US rare disease umbrella organization. Comparable role in the US rare disease ecosystem that EURORDIS plays in Europe, with overlapping policy advocacy and patient empowerment programs.
  • European Patients Forum (EPF): EU-level cross-disease patient advocacy umbrella. WDO supplies EPF's Toolkit on Patient Empowerment and participates in EPF Summer Training, positioning it as a peer in pan-European patient empowerment work.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

World Duchenne Organization social profiles

Digital presence

World Duchenne Organization financial estimates

Financial estimate

Revenue estimate

Valuation estimate

World Duchenne Organization leadership team

Management profile

Number of profiles

Profiles2 records

World Duchenne Organization funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

World Duchenne Organization M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about World Duchenne Organization

What does World Duchenne Organization do?

World Duchenne Organization is a Dutch nonprofit patient advocacy foundation that serves as a global hub for the Duchenne and Becker muscular dystrophy (DMD/BMD) community. It offers an annual international Duchenne Care Conference, the Duchenne Patient Academy online advocate training program, the annual World Duchenne Awareness Day campaign, and contributes to EU-funded research initiatives (BIND, BEAMER, ERDERA, EURO-NMD Registry Hub, Trials@Home). Its core product is a comprehensive information and community platform delivered through its website, supporting families, caregivers, clinicians, and patient organizations with condition information, care standards, and clinical trial guidance.

Is World Duchenne Organization a public or private company?

World Duchenne Organization is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was World Duchenne Organization founded?

World Duchenne Organization was founded in 2005. It employs 1 to 10 people.

Where is World Duchenne Organization based?

World Duchenne Organization is headquartered in Veenendaal, Netherlands, in the Europe region.

How does World Duchenne Organization make money?

One revenue line is on record: donations and Grants.

Who are World Duchenne Organization's main competitors?

Direct peers on record are Duchenne UK, EURORDIS - Rare Diseases Europe, Rare Diseases International, Parent Project Muscular Dystrophy (PPMD), Duchenne Data Foundation and TREAT-NMD Alliance. Broad incumbents are Muscular Dystrophy Association (MDA), AFM-Téléthon, National Organization for Rare Disorders (NORD) and European Patients Forum (EPF).

Does World Duchenne Organization have an API?

No public API is recorded for World Duchenne Organization.

What industry is World Duchenne Organization in?

World Duchenne Organization's product category is Patient Advocacy and Rare Disease Support Services. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of HLAJAKAN, Global Health Research, Evidence & Technical Assistance Organizations. Its NAICS code is 624190 and its SIC code is 8600.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals